Supplementary Figure S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates

Mark E. Petersen; Michael G. Brant; Manuel Lasalle; Samir Das; Renee Duan; Jodi Wong; Tong Ding; Kaylee J. Wu; Dayananda Siddappa; Chen Fang; Wen Zhang; Alex M. L. Wu; Truman Hirkala-Schaefer; Graham A. E. Garnett; Vincent Fung; Luying Yang; Andrea Hernández Rojas; Samuel O. Lawn; Stuart D. Barnscher; Jamie R. Rich; Raffaele Colombo

doi:10.1158/1535-7163.25735685

Abstract

Supplementary Figure S3 shows the in vitro cytotoxicity assessment of trastuzumab-ADCs in both two-dimensional (2D) and three-dimensional (3D) spheroid assays

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Petersen et al. (2024) studied this question.

synapsesocial.com/papers/68e6be8ab6db64358763e1c5 https://doi.org/10.1158/1535-7163.25735685

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates

Abstract

Discussion

Cite This Study

Supplementary Figure S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates

Abstract

Discussion

Cite This Study

Keep reading

Keep reading